medroxyprogesterone acetate has been researched along with Leukemia, Myeloid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Gudkova, V; Kolik, L; Konchekov, E; Kostukova, N; Miloykovich, L; Pavlik, T; Pavlova, M; Razvolyaeva, D; Shimanovskii, N | 1 |
Bavaro, P; Bellati, U; Bizzarri, M; Carabella, G; Iammarrone, E; Mattaeis, RD; Torlontano, G | 1 |
2 other study(ies) available for medroxyprogesterone acetate and Leukemia, Myeloid
Article | Year |
---|---|
The Role of Autophagy and Apoptosis in the Combined Action of Plasma-Treated Saline, Doxorubicin, and Medroxyprogesterone Acetate on K562 Myeloid Leukaemia Cells.
Topics: Apoptosis; Autophagy; Doxorubicin; Humans; K562 Cells; Leukemia, Myeloid; Medroxyprogesterone; Medroxyprogesterone Acetate; Saline Solution | 2023 |
[Efficacy of estrogen-progestin replacement therapy after bone marrow transplantation].
Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; beta-Thalassemia; Bone Marrow Transplantation; Child; Child, Preschool; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Medroxyprogesterone Acetate; Multiple Myeloma; Neural Tube Defects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Myelofibrosis; Primary Ovarian Insufficiency; Progesterone Congeners; Prospective Studies | 1996 |